Insufficient scRNA-seq data for expression of MAGEA6 at single-cell level.
Insufficient scRNA-seq data for expression of MAGEA6 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| ureter | 0% | 0 | 0 / 0 | 100% | 30.58 | 1 / 1 |
| skin | 0% | 0.02 | 1 / 1809 | 55% | 50.13 | 261 / 472 |
| esophagus | 0% | 0 | 0 / 1445 | 38% | 23.87 | 69 / 183 |
| lung | 0% | 0 | 0 / 578 | 30% | 25.45 | 350 / 1155 |
| bladder | 0% | 0 | 0 / 21 | 29% | 21.34 | 145 / 504 |
| liver | 0% | 0 | 0 / 226 | 21% | 12.88 | 85 / 406 |
| stomach | 0% | 0 | 0 / 359 | 21% | 11.89 | 59 / 286 |
| tonsil | 0% | 0 | 0 / 0 | 13% | 5.56 | 6 / 45 |
| intestine | 0% | 0 | 0 / 966 | 13% | 11.57 | 69 / 527 |
| uterus | 0% | 0 | 0 / 170 | 13% | 12.32 | 58 / 459 |
| breast | 0% | 0 | 0 / 459 | 8% | 6.96 | 89 / 1118 |
| pancreas | 0% | 0 | 0 / 328 | 7% | 3.93 | 12 / 178 |
| prostate | 0% | 0.14 | 1 / 245 | 2% | 0.33 | 8 / 502 |
| ovary | 0% | 0 | 0 / 180 | 2% | 0.69 | 8 / 430 |
| adrenal gland | 0% | 0 | 0 / 258 | 2% | 0.51 | 4 / 230 |
| kidney | 0% | 0 | 0 / 89 | 1% | 0.82 | 12 / 901 |
| thymus | 0% | 0.18 | 3 / 653 | 0% | 0 | 0 / 605 |
| muscle | 0% | 0.17 | 3 / 803 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 0.18 | 3 / 929 | 0% | 0 | 0 / 0 |
| brain | 0% | 0.05 | 4 / 2642 | 0% | 0.12 | 1 / 705 |
| adipose | 0% | 0.22 | 2 / 1204 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| blood vessel | 0% | 0 | 0 / 1335 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| heart | 0% | 0 | 0 / 861 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
| GO_0010507 | Biological process | negative regulation of autophagy |
| GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
| GO_0005575 | Cellular component | cellular_component |
| GO_0005634 | Cellular component | nucleus |
| GO_0005515 | Molecular function | protein binding |
| GO_0003674 | Molecular function | molecular_function |
| GO_0042826 | Molecular function | histone deacetylase binding |
| Gene name | MAGEA6 |
| Protein name | Melanoma-associated antigen 6 (Cancer/testis antigen 1.6) (CT1.6) (MAGE-6 antigen) (MAGE3B antigen) MAGEA6 protein MAGE family member A6 |
| Synonyms | MAGE6 |
| Description | FUNCTION: Activator of ubiquitin ligase activity of RING-type zinc finger-containing E3 ubiquitin-protein ligases that acts as a repressor of autophagy . May enhance ubiquitin ligase activity of TRIM28 and stimulate p53/TP53 ubiquitination by TRIM28. Proposed to act through recruitment and/or stabilization of the Ubl-conjugating enzyme (E2) at the E3:substrate complex . May play a role in tumor transformation or aspects of tumor progression . In vitro promotes cell viability in melanoma cell lines . . |
| Accessions | P43360 ENST00000616035.4 E7EUF2 ENST00000457643.1 ENST00000710006.1 E7ETG4 ENST00000412733.1 ENST00000329342.10 Q6FGT7 Q6FHI5 ENST00000710007.1 |